Oncternal Therapeutics, Inc. (ONCT)

Dec 3, 2024 - ONCT trading suspended

0.5266

-0.1670 (-24.12%)

Inactive · Last trade price on Dec 2, 2024

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 2, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	2	32	56	112	239	61
Market Cap Growth	-	-43.88%	-49.79%	-53.05%	293.15%	-
Enterprise Value	-13	-8	-14	15	218	38
Last Close Price	0.53	10.72	20.00	45.40	98.00	79.00

Price Ratios

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 2, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
PS Ratio	0.72	40.28	37.81	26.00	70.80	25.06
PB Ratio	0.17	1.05	0.92	1.27	2.12	4.25
P/TBV Ratio	0.17	1.05	0.92	1.27	2.12	4.25

EV Ratios

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 2, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
EV/Sales Ratio	-	-	-	3.46	64.62	15.63

Financial Efficiency

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 2, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Debt / Equity Ratio	0.02	0.01	0.00	0.00	0.00	0.01
Asset Turnover	0.07	0.01	0.02	0.04	0.05	0.11
Quick Ratio	2.31	6.71	8.32	16.78	19.93	2.73
Current Ratio	2.39	6.94	8.76	16.99	20.14	2.83
Return on Equity (ROE)	-149.86%	-86.75%	-59.25%	-31.17%	-27.07%	-214.06%
Return on Assets (ROA)	-74.11%	-49.48%	-34.63%	-18.46%	-15.60%	-42.96%
Return on Invested Capital (ROIC)	-93.35%	-57.03%	-37.64%	-19.49%	-17.20%	-58.43%

Yields

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 2, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Earnings Yield	-2218.41%	-124.86%	-78.40%	-27.93%	-7.21%	-56.25%
FCF Yield	-1708.77%	-101.72%	-65.15%	-23.70%	-7.32%	-27.55%
Buyback Yield / Dilution	-1.60%	-11.79%	-6.65%	-142.90%	-96.58%	-187.64%
Total Shareholder Return	-1.60%	-11.79%	-6.65%	-142.90%	-96.58%	-187.64%

SEC Filings: 10-K · 10-Q